After you spit into a tube for a DNA test like 23andMe, experts say you shouldn't assume your data will stay private forever
By Erin Brodwin,
Business Insider
| 02. 16. 2019
The data you shared with a genetic testing startup like 23andMe is private — for now.
But maintaining that privacy, which rests on your data being kept anonymous and secure, is getting harder, according to privacy experts, bioethicists, and entrepreneurs.
Your DNA data contains highly sensitive information about yourhealth and identity. Everything from your ancestry to your risk of cancer to information about allergies and predisposition to Alzheimer's are often included in a genetic test report. Whether it's a political figure claiming indigenous heritage or a CEO with a genetic risk for mental illness, any one of these factors could be used against someone if they got into the wrong hands.
The most prolific genetic testing companies take thorough steps to protect your privacy, such as scraping personal identifiers like your name from your genetic code before they sell that data to researchers or drug companies. They also typically store your personal information and your genetic data in separate environments to protect against a potential hack.
But those protocols do not protect against several key vulnerabilities, experts say.
One...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...